Health Tech & Pharma Delegation to Riyadh, Saudi Arabia

The Danish delegation to Riyadh will promote Danish health tech and pharma solutions to a market in demand of the long-term and cutting-edge products and services that Danish companies can supply. The delegation is jointly planned with the Danish Trade Council in Riyadh and will present Danish solutions to both private and public stakeholders in the market. The Confederation of Danish Industry and the Danish Trade Council in Riyadh are delighted to invite you to participate in a Health Tech and Pharma Delegation to Riyadh.

This delegation’s purpose is to engage Danish companies in present and forthcoming opportunities in the Saudi Arabian healthcare sector, which is experiencing unprecedented growth. DI and the Danish Embassy in Riyadh will set up B2B and B2G meetings, and networking events. This initiative meets a distinct demand from the Danish health sector to engage in the Saudi Arabian market.

WHO SHOULD JOIN?

The Health Tech Delegation to Riyadh is relevant for companies interested in expanding their operations in the Saudi Arabian market and in the overall MENA region. The mission is also an introduction to the Saudi Arabian market and could particularly be relevant for companies that specialise in but are not limited to:

• Medical devices
• Pharma
• Digital Health
• Hospital operation and management

Companies with an interest in building a network of business partners and/or expanding their business horizons in general should also participate.

WHY JOIN?

Saudi Arabia is investing heavily in their healthcare sector and plans to invest over $65 billion to develop the country’s healthcare infrastructure in their 2030 Vision. Further, the sector is experiencing a concentrated effort of privatisation and expanded use of Public–Private Partnerships (PPPs). The end goal of this privatisation is to increase private sector contribution to the health sector from 40% to 65% by 2030.

Non-communicable diseases account for 68% of all deaths in Saudi Arabia, with 18% of the adult population having diabetes, and more than 40% being obese. Correspondingly, in 2022, Saudi Arabia spent between 25% and 35% of the total healthcare budget on diabetes, obesity, and cardiovascular diseases. These are stronghold positions for Danish life science companies.

Tentative Agenda

The delegation will include business meetings and workshops with potential purchasers, distributors, and local partners for the participating Danish companies. This will facilitate the presentation of the Danish products, services, and technologies relevant to the Saudi Arabian market.

In addition, representatives will participate in meetings with government authorities, regarding several topics like procurement, tenders, policies, and regulations. These authorities will include the Ministry of Health, the Saudi Food and Drug Authority, the National Unified Procurement Company, and the National Center for Privatization, among other business groups such as hospitals and expanded medical cities.

Participating companies will have the opportunity to visit a medical city in Riyadh (a medical facility consisting of several hospitals with different specialisations, such as the obstetrics & gynecology hospital, the rehabilitation hospital, and the pediatric hospital, etc.). Through this site visit the delegates will tour around the medical cities departments - where they will be introduced to the various types of provided services and will see the steps of the health transformation journey. The tour will be concluded with a meeting between the Danish delegation and several medical city leaders to highlight healthcare opportunities.

Saudi Arabian Market Facts

Saudi Arabia has a population of 35 million people and had a GDP of 700 billion USD in 2020. The Saudi Arabian healthcare sector is undergoing one of the largest healthcare transformation programmes in the world and already accounts for 60% of the Gulf Cooperation Council (GCC) countries’ healthcare expenditure. This is equivalent to the Saudi Arabian Government spending 14.4% of their budget on healthcare (2022).

The Fine Print

The price is calculated based on 10 participating companies and a 50-pct. subsidy from the Danish Trade Council.

Registration is binding. If the number of participating companies’ changes, we reserve the right to offer participation at a different price. Should this result in a higher price than the one quoted, you have the right to cancel your participation.

Registration is in accordance with the general terms and conditions for participating  in DI’s export promotion events.

Travel, Accommodation and Transport Of Goods
Flights and hotels are not included in the price. But we will together with BCD Travel make a travel proposal for hotel and flight which you are welcome to use.